resveratrol has been researched along with Cardiomyopathies in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (11.11) | 29.6817 |
| 2010's | 13 (72.22) | 24.3611 |
| 2020's | 3 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, K; Lin, K; Shang, X; Wang, L; Xu, J; Yu, R; Zhang, Y; Zhu, P | 1 |
| Ahmad, R; Alanazi, A; Alhusaini, A; Fadda, L | 1 |
| Ahmad, I; Hoda, M | 1 |
| Alam, AS; Dyck, JRB; Eisenstat, DD; Ferdaoussi, M; Maayah, ZH; Matsumura, N; Soni, S; Takahara, S; Zordoky, BN | 1 |
| Abe, J; Harashima, H; Takeda, A; Yamada, Y | 1 |
| Basu, R; Das, SK; Dyck, JRB; Kassiri, Z; Oudit, GY; Patel, VB; Zhabyeyev, P | 1 |
| Lu, X; Lu, Y; Wang, L; Yang, W | 1 |
| Berrino, L; Cappetta, D; Ciuffreda, LP; De Angelis, A; Esposito, G; Fagnoni, F; Ferraiolo, FA; Frati, C; Piegari, E; Quaini, F; Rossi, F; Russo, R; Urbanek, K | 1 |
| Horio, Y; Kuno, A; Tanno, M | 1 |
| Basu, R; Das, SK; DesAulniers, J; Dyck, JR; Fan, D; Hajjar, RJ; Kassiri, Z; McLean, B; Oudit, GY; Parajuli, N; Patel, VB; Wang, W; Zhabyeyev, P | 1 |
| Berrino, L; Cappetta, D; Ciuffreda, LP; De Angelis, A; Esposito, G; Piegari, E; Rivellino, A; Rossi, F; Russo, R; Urbanek, K | 1 |
| An, R; Li, H; Shen, G; Sun, L; Xi, C; Xu, J; Zhang, S; Zhang, W; Zhao, L | 1 |
| Hueckstaedt, LK; Li, Q; Ren, J | 1 |
| Gupta, M; Gupta, MP; Matta, MJ; Periasamy, M; Sulaiman, M; Sunderesan, NR | 1 |
| Alp, E; Menevse, S; Yar, AS | 1 |
| dos Santos, CC; Furmli, S; Haitsma, JJ; Horvath, E; Hu, P; Kuiper, JW; Leong-Poi, H; Masoom, H; Parker, TG; Plötz, FB; Shan, Y; Slutsky, AS; Smeding, L | 1 |
| Hori, YS; Horio, Y; Hosoda, R; Kuno, A; Miura, T; Shimamoto, K; Tanno, M | 1 |
| Kelly, JW; Klabunde, T; Oza, VB; Petrassi, HM; Raman, P; Sacchettini, JC | 1 |
2 review(s) available for resveratrol and Cardiomyopathies
| Article | Year |
|---|---|
Molecular mechanisms of action of resveratrol in modulation of diabetic and non-diabetic cardiomyopathy.
Topics: Animals; Antioxidants; Cardiomyopathies; Diabetic Cardiomyopathies; Disease Models, Animal; Humans; Myocytes, Cardiac; Oxidative Stress; Resveratrol; Signal Transduction | 2020 |
The effects of resveratrol and SIRT1 activation on dystrophic cardiomyopathy.
Topics: Animals; Cardiomyopathies; Cardiotonic Agents; E1A-Associated p300 Protein; Enzyme Activation; Humans; Muscular Dystrophy, Duchenne; Proteolysis; Resveratrol; Sirtuin 1; Stilbenes; Ubiquitination | 2015 |
16 other study(ies) available for resveratrol and Cardiomyopathies
| Article | Year |
|---|---|
Resveratrol Protects the Myocardium in Sepsis by Activating the Phosphatidylinositol 3-Kinases (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Pathway and Inhibiting the Nuclear Factor-κB (NF-κB) Signaling Pathway.
Topics: Animals; Apoptosis; Cardiomyopathies; China; Chromones; Disease Models, Animal; Heart; Male; Morpholines; Myocardium; NF-kappa B; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Resveratrol; Sepsis; Signal Transduction; TOR Serine-Threonine Kinases; Tumor Necrosis Factor-alpha | 2019 |
Antioxidant, antiapoptotic, and antifibrotic effects of the combination of liposomal resveratrol and carvedilol against doxorubicin-induced cardiomyopathy in rats.
Topics: Animals; Antibiotics, Antineoplastic; Antioxidants; Apoptosis; Cardiomyopathies; Cardiotoxicity; Carvedilol; Caspase 3; Doxorubicin; Drug Therapy, Combination; Heart; Liposomes; Male; Myocardium; NF-kappa B; Rats; Rats, Wistar; Resveratrol; Signal Transduction; Transforming Growth Factor beta1 | 2020 |
Resveratrol reduces cardiac NLRP3-inflammasome activation and systemic inflammation to lessen doxorubicin-induced cardiotoxicity in juvenile mice.
Topics: Animals; Cardiomyopathies; Cardiotoxicity; Doxorubicin; Inflammasomes; Male; Mice; NLR Family, Pyrin Domain-Containing 3 Protein; Resveratrol | 2021 |
Cardiac progenitor cells activated by mitochondrial delivery of resveratrol enhance the survival of a doxorubicin-induced cardiomyopathy mouse model via the mitochondrial activation of a damaged myocardium.
Topics: Animals; Antibiotics, Antineoplastic; Cardiomyopathies; Cell Line; Coculture Techniques; Disease Models, Animal; Doxorubicin; Male; Mice, Inbred C57BL; Mitochondria, Heart; Myocardium; Resveratrol; Stem Cell Transplantation; Stem Cells | 2018 |
Advanced iron-overload cardiomyopathy in a genetic murine model is rescued by resveratrol therapy.
Topics: AMP-Activated Protein Kinase Kinases; Animals; Cardiomyopathies; Disease Models, Animal; GPI-Linked Proteins; Heart; Hemochromatosis Protein; Hepcidins; Humans; Iron; Iron Overload; Membrane Proteins; Mice; Myocardium; Oxidative Stress; Protein Kinases; Resveratrol; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Sodium-Calcium Exchanger; Stilbenes | 2018 |
Resveratrol attenuates high fat diet-induced mouse cardiomyopathy through upregulation of estrogen related receptor-α.
Topics: Adenosine Triphosphate; Animals; Cardiomyopathies; Cardiotonic Agents; Diet, High-Fat; ERRalpha Estrogen-Related Receptor; Male; Mice, Inbred C57BL; Myocardium; Obesity; Receptors, Estrogen; Resveratrol; Up-Regulation | 2019 |
SIRT1 activation rescues doxorubicin-induced loss of functional competence of human cardiac progenitor cells.
Topics: Analysis of Variance; Animals; Apoptosis; Blotting, Western; Cardiomyopathies; Cells, Cultured; Disease Models, Animal; Doxorubicin; Female; Humans; Immunohistochemistry; Myocytes, Cardiac; Normal Distribution; Random Allocation; Rats; Rats, Inbred F344; Resveratrol; Sirtuin 1; Statistics, Nonparametric; Stem Cells; Stilbenes | 2015 |
Iron-overload injury and cardiomyopathy in acquired and genetic models is attenuated by resveratrol therapy.
Topics: Animals; Cardiomyopathies; Disease Models, Animal; Down-Regulation; Fibroblasts; Fibrosis; Forkhead Box Protein O1; Forkhead Transcription Factors; Genetic Therapy; GPI-Linked Proteins; Hemochromatosis Protein; Humans; Iron Overload; Male; Membrane Proteins; Mice, Inbred C57BL; Mice, Knockout; Models, Genetic; Myocardium; Myocytes, Cardiac; Oxidants; Oxidative Stress; Resveratrol; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Signal Transduction; Sirtuin 1; Stilbenes | 2015 |
SIRT1 activation attenuates diastolic dysfunction by reducing cardiac fibrosis in a model of anthracycline cardiomyopathy.
Topics: Animals; Anthracyclines; Antibiotics, Antineoplastic; Cardiomyopathies; Cells, Cultured; Diastole; Disease Models, Animal; Doxorubicin; Female; Fibrosis; Rats; Rats, Inbred F344; Resveratrol; Sirtuin 1; Stilbenes | 2016 |
Resveratrol alleviates sepsis‑induced myocardial injury in rats by suppressing neutrophil accumulation, the induction of TNF‑α and myocardial apoptosis via activation of Sirt1.
Topics: Animals; Apoptosis; Cardiomyopathies; Disease Models, Animal; Male; Neutrophil Infiltration; Neutrophils; Rats; Resveratrol; Sepsis; Sirtuin 1; Stilbenes; Tumor Necrosis Factor-alpha | 2016 |
The protease inhibitor UCF-101 ameliorates streptozotocin-induced mouse cardiomyocyte contractile dysfunction in vitro: role of AMP-activated protein kinase.
Topics: Acetylcysteine; AMP-Activated Protein Kinases; Animals; Antioxidants; Calcium-Binding Proteins; Cardiomyopathies; Diabetes Complications; Diabetes Mellitus, Experimental; High-Temperature Requirement A Serine Peptidase 2; In Vitro Techniques; Male; MAP Kinase Signaling System; Mice; Mitochondrial Proteins; Myocardial Contraction; Myocytes, Cardiac; Protease Inhibitors; Pyrimidinones; Resveratrol; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Serine Endopeptidases; Stilbenes; Streptozocin; Thiones; X-Linked Inhibitor of Apoptosis Protein | 2009 |
Resveratrol, an activator of SIRT1, upregulates sarcoplasmic calcium ATPase and improves cardiac function in diabetic cardiomyopathy.
Topics: Animals; Antioxidants; Cardiomyopathies; Diabetes Mellitus, Experimental; Disease Models, Animal; Male; Mice; Mice, Inbred Strains; Mice, Knockout; Myocardium; Myocytes, Cardiac; Resveratrol; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Sirtuin 1; Stilbenes; Streptozocin; Up-Regulation | 2010 |
The effects of resveratrol on cyclooxygenase-1 and -2, nuclear factor kappa beta, matrix metalloproteinase-9, and sirtuin 1 mRNA expression in hearts of streptozotocin-induced diabetic rats.
Topics: Animals; Antioxidants; Cardiomyopathies; Cyclooxygenase 1; Cyclooxygenase 2; Diabetes Mellitus, Experimental; Disease Models, Animal; Gene Expression Regulation; Heart; Male; Matrix Metalloproteinase 9; NF-kappa B; Rats; Rats, Wistar; Real-Time Polymerase Chain Reaction; Resveratrol; RNA, Messenger; Signal Transduction; Sirtuin 1; Stilbenes | 2011 |
Salutary effect of resveratrol on sepsis-induced myocardial depression.
Topics: Animals; Cardiomyopathies; Cecum; Down-Regulation; Edema; Gene Expression; Heart Failure; Ligation; Male; Mice; Mice, Inbred C57BL; Mitochondria, Heart; Myocardial Contraction; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Random Allocation; Resveratrol; Sepsis; Stilbenes; Trans-Activators; Transcription Factors; Vasodilator Agents | 2012 |
Resveratrol improves cardiomyopathy in dystrophin-deficient mice through SIRT1 protein-mediated modulation of p300 protein.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cardiomegaly; Cardiomyopathies; Down-Regulation; Dystrophin; E1A-Associated p300 Protein; Echocardiography; Male; Mice; Mice, Inbred C57BL; Models, Biological; Phenylephrine; Proteasome Endopeptidase Complex; Resveratrol; Sirtuin 1; Stilbenes; Ubiquitin | 2013 |
Rational design of potent human transthyretin amyloid disease inhibitors.
Topics: Amino Acid Sequence; Amyloid Neuropathies; Anti-Inflammatory Agents, Non-Steroidal; Benzofurans; Binding Sites; Cardiomyopathies; Crystallography, X-Ray; Dicarboxylic Acids; Diclofenac; Drug Design; Flurbiprofen; Humans; Hydrogen Bonding; Models, Molecular; Molecular Sequence Data; ortho-Aminobenzoates; Oxazines; Prealbumin; Protein Structure, Quaternary; Resveratrol; Stilbenes; Structure-Activity Relationship; Thermodynamics | 2000 |